Delving into the Latest Updates on Chongqing Bovax Biopharmaceutical with Synapse

Overview

Basic Info

Introduction

Chongqing Bovax Biopharmaceutical Co. Ltd is a production-oriented enterprise that specializes in the research and industrial production of recombinant protein vaccines and recombinant protein drugs, and is a wholly-owned subsidiary of Shanghai Bowei Biotech Co. Ltd. Bowei Biotech possesses advanced international genetic engineering techniques (VLP technology) that can be applied to the development of new preventive vaccines for cancer and infectious diseases, including cervical cancer and hand-foot-and-mouth disease.

Disease Domain	Count

Infectious Diseases	4
Neoplasms	1

Top 5 Drug Type	Count

Prophylactic vaccine	3
Vaccine	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Application

2

1

Phase 1 Clinical

Phase 3 Clinical

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Quadrivalent HPV recombinant vaccine (Shanghai Bovax Biotechnology)	Human Papillomavirus Infection More	Phase 3
Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)	Enterovirus 71 infection More	Phase 1
Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)	Human Papillomavirus Infection More	IND Application
Recombinant 17-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)	Human Papillomavirus Infection More	IND Application